MMP-13 siRNA (h) from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images
Published Figures

MMP-13 siRNA (h)

Be the first to write a review!

Citations:

Figures:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
MMP-13 siRNA (h)

Description

MMP-13 siRNA (h)

Product Specs
ItemMMP-13 siRNA (h)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-41559
Gene Namematrix metallopeptidase 13 (collagenase 3)
Quantity10 µM
Specieshuman
NCBI Full Gene Namematrix metallopeptidase 13
NCBI Gene AliasesCLG3, MANDP1, MDST, MMP-13
TypesiRNA/dsRNA

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Matrix metalloproteinase-13 is a target gene of high-mobility group box-containing protein 1 in modulating oral cancer cell invasionJournal of cellular physiologyApril 1, 2019Chan CY, Lin TY, Sheu JJ, Wu WC, Huang CY.

(2) Polyphosphate-induced matrix metalloproteinase-13 is required for osteoblast-like cell differentiation in human adipose tissue derived mesenchymal stem cellsBioscience trendsNovember 15, 2016Ozeki N, Mogi M, Hase N, Hiyama T, Yamaguchi H, Kawai R, Nakata K.

(3) Ataxia-telangiectasia mutated activation mediates tumor necrosis factor-alpha induced MMP-13 up-regulation and metastasis in lung cancer cellsOncotargetSeptember 20, 2016Yan HQ, Zhang D, Shi YY, You X, Shi L, Li Q, Gao FG.(sc-29761), NFκB p65 siRNA (sc-29410), hMMP3 siRNA (sc-29399), hMMP9 siRNA (sc-29400), hMMP13 siRNA (sc-41559) and control siRNA (sc-37007). p38 MAPK siRNA (#6564) and p44/42 MAPK (Erk1/2) siRNA (#6560) were obtained from

(4) Bone morphogenetic protein-induced cell differentiation involves Atg7 and Wnt16 sequentially in human stem cell-derived osteoblastic cellsExperimental cell researchSeptember 10, 2016Ozeki N, Mogi M, Hase N, Hiyama T, Yamaguchi H, Kawai R, Matsumoto T, Nakata K.

(5) Wnt16 Signaling Is Required for IL-1β-Induced Matrix Metalloproteinase-13-Regulated Proliferation of Human Stem Cell-Derived Osteoblastic CellsInternational journal of molecular sciencesFebruary 6, 2016Ozeki N, Mogi M, Hase N, Hiyama T, Yamaguchi H, Kawai R, Kondo A, Nakata K.Transfection Wnt16, Lrp5, and MMP-13 siRNAs for gene silencing were acquired commercially (sc-41128, sc-43900 and sc-41559, respectively; Santa Cruz Biotechnology Inc.) and transfected into cultured cells using an siRNA reagent system

(6) Host and tumor derived MMP13 regulate extravasation and establishment of colorectal metastases in the liverMolecular cancerFebruary 22, 2015Mendonsa AM, VanSaun MN, Ustione A, Piston DW, Fingleton BM, Gorden DL.

(7) Shedding of NG2 by MMP-13 attenuates anoikisDNA and cell biologyDecember 1, 2014Joo NE, Miao D, Bermúdez M, Stallcup WB, Kapila YL.

(8) IL-6 increases MMP-13 expression and motility in human chondrosarcoma cellsThe Journal of biological chemistryApril 1, 2011Tang CH, Chen CF, Chen WM, Fong YC.

(9) Glial cell line-derived neurotrophic factor induces cell migration and matrix metalloproteinase-13 expression in glioma cellsBiochemical pharmacologyOctober 15, 2010Lu DY, Leung YM, Cheung CW, Chen YR, Wong KL.

(10) CTGF enhances migration and MMP-13 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cellsJournal of cellular biochemistryMay 15, 2009Tan TW, Lai CH, Huang CY, Yang WH, Chen HT, Hsu HC, Fong YC, Tang CH.

(11) Cyr61 increases migration and MMP-13 expression via alphavbeta3 integrin, FAK, ERK and AP-1-dependent pathway in human chondrosarcoma cellsCarcinogenesisFebruary 1, 2009Tan TW, Yang WH, Lin YT, Hsu SF, Li TM, Kao ST, Chen WC, Fong YC, Tang CH.

(12) Bone morphogenetic protein-2 enhances the motility of chondrosarcoma cells via activation of matrix metalloproteinase-13BoneFebruary 1, 2009Hou CH, Hsiao YC, Fong YC, Tang CH.

Be the First to Write a Review!